Anavex Life Sciences Corp (AVXL)

[xodcode]

AVXL could experience a short squeeze soon!!!

Well, we shall know tomorrow if that likelihood is to be realized this week or a month from this week. If AVXL is listed tomorrow, this week will almost certainly see significant price strengthening culminating with a huge price spike through Friday and Monday.

With 32 million plus shares or 37% of AVXL shares shorted, it is difficult to imagine anything but an AVXL price multiples higher upon release of positive EMA news.

Given the JPAD publication earlier this year, with CS1 now behind us and with historical stats demonstrating that fewer than 5% EMA accepted submissions fail, it is virtually a lock that CHMP will recommend Blarcamesine for approval.

So, gents, strap in and enjoy the trip of your lives, because if included in tomorrow's CHMP listing, AVXL shares are soon to be price multiples higher from this past Friday's close as shorts rapidly jettison their short positions.

Any rational analysis demonstrates conclusively that when Blarcamesine is recommended for approval, a short tsunami will necessarily follow as shorts flood the exits!

Oh, and yes, WGT!